Published: June 19th 2024 | Updated: June 24th 2024
Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors
Published: August 27th 2025 | Updated: September 17th 2025
Bridging the Gap Between Innovation and Access: Q&A with Matt Riordan
Published: June 3rd 2025 | Updated: September 17th 2025
Bridging Vision and Value: How Target Product Profiles and Value Evidence Archetypes Must Align for Market Access Success
Published: August 18th 2025 | Updated: September 17th 2025
Going Beyond Compliance: Early Adoption of FDA’s Quality Management Maturity Program—and the Practical Considerations for Executives
Published: September 3rd 2025 | Updated: September 17th 2025
What Are the Core Tenets of Diagnostics 2.0?
Published: September 2nd 2025 | Updated: September 17th 2025
What are Diagnostics 2.0?